Hand hygiene has been identified as one of the simplest, but the most significant measure to prevent and control the spread of hospital acquired infections (WHO, 2009). Furthermore, it is also considered a cheap measurement for infection control (Allegranzi et al., 2007). Hand hygiene compliance among healthcare workers is underutilised and interventions to develop it are absent sustainability in developing countries (Gould et al., 2008). In the mid-1880s, the Austrian physician Ignaz P. Semmelweis was the first doctor who reported the critical role of the hands of the healthcare providers in transmitting hospital acquired infections (Allegranzi and Pittet, 2008). Hospital-acquired infections (HAI) remain a big challenge to the patient safety (WHO, 2009). It affects hundreds of million individuals worldwide ever year (Allegranzi et al., 2007). Healthcare-associated infection is regarded as one of the main reasons for long staying longer in hospitals, increasing the cost of the patient treatment, and causing higher morbidity and mortality rates (Mathai
Healthcare is an ever-growing, booming industry and as medical technology advances so should our standards of care. Once known as hospital acquired “nosocomial” infections, Healthcare Associated Infections (HAIs) are still afflicting the very patients we are to be treating. These patients could be our loved ones, friends, and family so to say that, “1 in 25 hospital patients have at least one HAI in a U.S. acute care hospital” (CDC, 2015), is still one too many.
Hospital acquired infections (HAI) will begin to display signs and symptoms within 48 hours. In order to treat the infections, physicians need to diagnostic tools quickly. The manufacturer of new diagnostic test makers, Kalorama Information stated last year that the world demand for testing and treatment of HAI will be over 10 billion dollars by the year 2015, increasing from 9 billion dollars in 2010. Kalorama also stated that HAI has a 5% infection rate of 40 million hospital visits a year, causing 100,000 deaths in the U.S. annually (Kalorama Information, July 14, 2011). Early diagnosis will improve the patient's outcome and decrease the chance of death. According to Kalorama, 20-30% of the HAI can be prevented by the simple use of better hand washing and cross contamination avoidance although the others need more intensive changes such as hospital ventilation systems and using more disposable supplies (Kalorama Information, p. 113) .
Preventable infections regardless of the causative agent, have become major triggers of unintended patient outcome, increased morbidity, and mortality (Arias, 2010). Methicillin Sensitive Staphylococcus Aureus (MSSA) and Methicillin Resistant Staphylococcus Aureus (MRSA) are the most common causes of healthcare associated infections (HAI) and outbreaks in acute care hospitals and community settings (CADTH, 2010). The widespread infection with the MRSA pathogen is believed to have increased from 2.4 percent in 1975 to 29 percent in 1991 and 2003 in hospitals across the United States (U S) (CADTH, 2010). The prevalence is even greater among Intensive Care Unit (ICU) patients at 53 percent (CADTH, 2010) and continues to rise due to the widespread
The occurrence and undesirable complications from hospital acquired infections (HAIs) have been well recognized for the last several decades. The occurrence of HAIs continues to escalate at an alarming rate. HAIs originally referred to those infections associated with admission in an acute-care hospital (formerly called a nosocomial infection). These unanticipated infections develop during the course of health care treatment and result in significant patient illnesses and deaths (morbidity and mortality); prolong the duration of hospital stays; and necessitate additional diagnostic and therapeutic
Hospital-acquired infections (HAIs), specifically those involving multi-drug resistant organisms such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) are associated with increased morbidity and mortality, as well as higher cost of healthcare and longer length of hospital stays for patients. Each year, millions of people acquire infections while receiving care, treatment, and services in hospitals and other health care organizations.
Each state can compare its statistical data to the standardized infection ratio (SIR), a summarized ratio of the culmination of national data; this is an excellent method to track the progress in the goal of reducing and eventually eradicating HAIs. The report for the state of Kentucky on HAIs in the state’s acute care hospitals was based on information received from a total of 116 hospitals that provided data for this survey. Unfortunately, the incidence of reported HAIs associated with Methicillin-resistant Staphylococcus aureus (MRSA), a type of laboratory identified hospital-onset bloodstream infection, is extremely high. Kentucky’s reported incidences in 2014 of patients infected with MRSA while being treated in acute care hospitals is 25% higher than the national baseline. This information is a red flag for the state’s epidemiology experts and healthcare professionals, that infection control protocol in place should be reviewed and researched to determine what can be done, either on a hospital-to-hospital based level or a state-wide level, to improve the efficiency of reducing or eliminating HAIs that are associated with MRSA infections. One area that the state’s statistical data rates very well is in Central Line-Associated Bloodstream Infections (CLABSIs). Kentucky’s number of reported incidences of this type of infection is 45% lower than the national baseline, suggesting that the protocol used for this type of infection is very effective compared to what is practiced in other
Peripherally inserted central catheters (PICCs) can be used for routine patient care for treatment and have been increasingly used over the past years. They are more invasive than a peripheral intravenous line (PIV); however, they can be inserted at the bedside, are easily removed, and provide many positive benefits. PICCs relieve patients from frequent venipuncture for serial lab draws, decreases frequent re-starts of PIVs, and the patient can be discharged home, if needed, for continued IV therapy. Although there are benefits to these easily inserted central lines, central line-associated bloodstream infections (CLABSI) are a possibility (Dumont & Nessselrodt, 2012).
Checking in to the hospital comes with a heavy price tag, and sometimes you get more than what you bargained for. As highly trained doctors, nurses, and staff traverse through the hospital, they carry with them microbial agents of disease. Although regarded as centers for treatment and prevention, hospitals are also known to harbor nosocomial, healthcare-associated, bacterial infections. These infections can be a result of overused or inappropriately used antibiotics and the breaching of infection containment policies by patients and staff. Though healthcare-associated infections have been decreasing, one infection inciting nosocomial bacterium,
Hospital acquired infections (HAI) are never good. Moreover, according to the Centers for Disease Control and Prevention, one in 25 patients will develop an infection which was procured during their stay in a hospital (Centers for Disease Control and Prevention, 2015). Twenty percent of these HAI are due to staphylococcus aureus, better known as simply Staph (Statisticbrain.com, 2015).
More than one million of Healthcare associated infections happen across healthcare settings every year, or 1 in 20 people admitted to any healthcare setting (Healthy people 2020, 2013). HAIs are the most common complication seen in hospitalized patients. HAIs increase morbidity, mortality, healthcare costs, and length of stay even after adjustment for the main underlying illness. According to the Center for Diseases Control (CDC, April 2013) 5 to 10% of patients admitted to acute-care hospitals, or long-term care facilities approximately 2 million patients per year in the United States acquire a nosocomial infection. At least 90,000 deaths per year are a result of HAIs, making it the fifth leading cause of death in acute-care hospitals. These
Methicillin-resistant Staphylococcus aureus (MRSA) is a drug resistant pathogen abundant in healthcare settings and the second most common overall cause of healthcare associated infections (HAIs) reported to the National Healthcare Safety Network (NHSN) (Jernigan & Kallan, 2010). The prevalence of MRSA is a significant problem found amongst many Intensive Care Units (ICUs) in the United States (US); critically ill patients are at higher risk for hospital-acquired infections. Acquisition and infection of MRSA may significantly prolong duration of hospital stays, increase healthcare costs, and contribute to higher mortality rates. According to national data, MRSA accounts for nearly 70 percent of Staphylococcus aureus strains isolated from
Hospital settings have harbored a disease-causing organism called Methicillin-resistant Staphylococcus aureus (MRSA) since the 1960s. However, hospitals aren’t the only settings at risk of a MRSA outbreak. In recent years’ healthy communities have seen a genetically distinct strain of MRSA, called community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA). Although this organism has been less resistant to antibiotics, it is more virulent and capable of causing illnesses (Alex & Letizia, 2007). The community should be aware of the risk factors for this infection and understand its signs, symptoms, and management.
HAIs are usually unrelated to the original illness that the patient presents with. Studies have shown that hospital infections increase financial cost of care, morbidity, and mortality rates. Many causes can contribute to patients acquiring infections during a hospital stay. An increase of large number of patients with several diseases into a hospital with a decreased immune system, medical procedures that bypass the body's natural protective barriers, staff can carry pathogens from patients to patients, failure to follow preventative measures to prevent the spread of infection by staff, and a routine use of antimicrobials that creates resistance are just some of the few reasons why HAI occur (Revelas,
Health care acquired infection (HCAI) exerts a massive impact on the health care services delivery and improvement of its quality. It has been reported among leading culprits of prolonged admission, increased mortality, long-term disability and complications, emergence of multidrug resistant organism (MDRO), and they are costing healthcare services a great deal of money.(1, 2) At a given time, occurrence of HCAI is 15.5 per 100 patients in developing countries and 5 to 12 per 100 patients in developed countries. It is estimated that approximately 1 out of every 20 hospitalized patients will contract an HCAI.(3) In a summery and updating reviews done in 2014 by WHO concluded that more than a quarter of the MERS-cov infections have been